NASDAQ NMS - GLOBAL MARKET · HURA
-7.69% · -$0.1900 · Vol 517.0K
Market closed · last close 4:00 PM ET · price as of 18:27:18 ET
TuHURA Biosciences Inc

TuHURA Biosciences Inc

Biotechnology
$2.28
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
HURA
TuHURA Biosciences Inc
Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
SELL BIAS

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

41/ 100
Veridion Score
SELL BIAS · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 17 · last completed session · Markets closed · resumes Tue 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is HURA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading HURA catalysts
About TuHURA Biosciences Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Employees
22
Country
US

TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.42
Day high
$2.48
Day low
$2.27
Previous close
$2.47
52W high
$3.25
-29.85% from high
52W low
$0.4400
65% of range
Market cap
$157.3M
EPS
$-0.6200
Beta
2.80
Shares out
63.7M
Volume
517K
1.69× rel vol
Avg volume
305.8K
VWAP
$2.35
Price history computed in-house
1W
-0.87%
1M
+1.33%
3M
-4.60%
1Y
-26.21%
YTD
+201.31%
SMA 50 $2.26 · above
SMA 200 $1.83 · above
52W position 65%

HURA overview

Loading financial statements
Loading HURA Form 4 filings
Public disclosures

Congress activity in HURA

Laurel LeeBuyspouse

TuHURA Biosciences, Inc. - Common Stock · Transaction Jul 13, 2025 · Filed Aug 9, 2025 · $50,001 to $100,000

Official filing ↗
Laurel LeeBuyspouse

TuHURA Biosciences, Inc. - Common Stock · Transaction Nov 25, 2024 · Filed Jan 7, 2025 · $1,001 to $15,000

Official filing ↗
Laurel LeeExchangespouse

TuHURA Biosciences, Inc. - Common Stock · Transaction Oct 18, 2024 · Filed Nov 21, 2024 · $100,001 to $250,000

Official filing ↗
Federal contracts

HURA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HURA in this window.
Lobbying spend

HURA lobbying filings, year to date.

Registered lobbying filings matched to TuHURA Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HURA in this window.
Loading news for HURA
Analyst ratings
Sovereign unlock shows live analyst consensus for HURA.
Options
Sovereign unlock shows live options positioning for HURA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.